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Cardiovascular disease accounts for 43% of all deaths in patients with end-
stage renal disease, and CVD continues to remain the leading cause of mor-
tality and morbidity following renal transplantation. However, the characteris-
tics and the hospital mortality of acute myocardial infarction (AMI) in patients
with kidney transplantation (KT) remain to be determined in large scale study.
From the French nationwide hospital medical information database, all the
consecutive patients hospitalized in the 1546 French hospital/clinics for AMI
from 1st January 2005 to 31st December 2009 were included. We compared
the specific profile and the hospital mortality of patients with KT to patients
without renal failure. Patients with personal past history of renal failure and/
or dialysis were excluded. 
Among the 329 839 patients with AMI included, 404 (0.1%) patients were
after KT. Patients with KT were more frequently men (78.7 vs 66.8%, with
p<0.001), markedly younger (58±12 vs 68±11, with p<0.001), and les smoker
(5.0 vs 9.1%, with p<0.001) than patients without KT. There was also a higher
proportion of hypertension (28.5 vs 23.4%, with p0.017) and a lower propor-
tion of STEMI (75.7 vs 82.7%, with p<0.001) in patients after KT. More than
two-thirds of AMI complicating post KT period occured before discharge
(67.1%) and 91% in the first year after KT. After adjustment for age, sex and
STEMI, in-hospital mortality was higher in KT group (4.2 vs 2.9%), but with
p=0.210.
From our large scale nationwide study, our work demonstrated that patients
with KT complicated by AMI are markedly younger with a specific difference
for usual risk factors, but transplant-related risk factors explain also this spec-
ificity. We highligts that AMI occurs very early after KT, most often before
discharge. To decrease the frequency of MI following renal transplantation,
screening of coronaropathy and evaluation of risk factors before KT, as well
as after KT must be evaluated.
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Objective: Data from randomized trials evaluating thrombus aspiration
(TA) in patients with ST-Elevation Myocardial Infarction (STEMI) are con-
flicting. Therefore, we assessed one-year survival in STEMI patients partici-
pating in the FAST-MI (French Registry of ST-elevation and non-ST-
elevation Myocardial Infarction) 2010 according to TA during primary percu-
taneous coronary intervention (PCI), such as used in the real world.
Methods: FAST-MI 2010 is a nationwide French registry that included
4,169 patients with acute myocardial infarction (AMI) at the end of 2010 in
213 centres. Of those, 2,087 patients had STEMI or left bundle branch block
(LBBB), of whom 1,538 had primary PCI, with TA used in 671 (44%).
Results: Patients with TA were younger (61±13.5 vs. 63±14 years), with a
similar GRACE (Global Registry of Acute Coronary Events) risk score
(140±31 vs. 143±34), and a shorter median time from symptom onset (245 vs.
285 min); location of AMI, history of MI, PCI or coronary artery bypass sur-
gery did not differ significantly. Thirty-day mortality was 2.1% vs. 2.1%
(adjusted p=0.18) and one-year survival was 95.5% vs. 94.8%. Using fully
adjusted Cox multivariate analysis, hazard ratio for one-year death was 1.14
(95% confidence interval [CI], 0.63 to 2.07). After propensity score matching
(480 patients per group), one-year survival was also similar with both strate-
gies.
Conclusions: In a real-world setting of patients admitted with STEMI, the
use of TA during primary PCI was not associated with improved one-year sur-
vival. 
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Background: There are limited data on outcomes following primary per-
cutaneous coronary intervention (PCI) for ST-segment elevation acute myo-
cardial infarction (STEMI) in nonagenarian patients.
Methods and Results: We conducted a multicentre retrospective study
between 2006 and 2013 in 5 international high-volume centers and included
145 nonagenarians treated with primary PCI for STEMI. Cardiogenic shock
was present at admission in 21%. Mean delay between symptom onset and
balloon was 5,8±7,6 hours and 60% of procedures were performed through the
transradial approach. Successful revascularization of the culprit vessel was
obtained in 86% of the cases (TIMI flow of 2 or 3). Major or clinically-rele-
vant bleeding was observed in 4% of patients. Mean cardiac troponin Ic was
65±79 ng/ml and mean LVEF post-PCI was 42±13%. The in-hospital mor-
tality was 24% with 6 months and 1 year survival of 58% and 49% respec-
tively.
Conclusions: In our study, primary PCI in nonagenarians with STEMI
was successful and feasible through a transradial approach. It is associated
with a high rate of successful reperfusion of the infarct-related artery and
nearly 50% survival at one year. These results suggest that primary PCI
should be offered in selected nonagenarians with acute myocardial infarction
(table next page).
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Purpose: Stroke is a serious complication after acute myocardial infarction
(AMI) and is closely associated with poor prognosis. This study aimed to
investigate the frequency, the characteristics and factors associated with in-
hospital and postdischarge stroke in patients with AMI. 
Methods: 8485 consecutive patients admitted in intensive care unit (ICU)
between January 2001 and June 2010 were included. Among other major
adverse cardiac events (MACE), both stroke and transient ischemic attack
(TIA) were collected during one-year follow-up. 
Results: 168 (1.98%) strokes were recorded during the first year of follow-up
after AMI. In-hospital strokes (IHS) occurred in 123 patients (1.4%), and 87% of
them in the first five days after admission in ICU. After multivariate logistic
regression analysis, IHS was independently associated with female sex (OR: 1.73,
95% CI: 1.19-2.51, p=0.004), previous stroke/TIA (OR: 2.21, 95% CI: 1.28-3.83,
p=0.004), LVEF (OR: 0.96, 95% CI: 0.95-0.98, p<0.001), new onset atrial fibril-
lation (AF) (OR: 1.99, 95% CI: 1.25-3.16, p=0.004) and C-reactive protein (CRP)
(OR 1.006, 95% CI: 1,003-1,009, p<0.001). Patients developing an in-hospital
stroke had an increased risk of death at one year after adjustment to other prog-
nostic factors (OR: 1.82, 95% CI: 1.05-3.15, p=0.031). Among surviving patients
(n=7808), postdischarge stroke (PDS) occurred in 45 patients (0.64%) within one-
year follow-up after AMI. After multivariate logistic regression analysis, PDS
was independently associated with age (OR: 1.04, 95% CI: 1.01-1.07, p=0.003),
previous stroke/TIA (OR: 3.69, 95% CI: 1.83-7.43, p<0.001) and systemic hyper-
tension (OR: 2.77, 95% CI: 1.26-6.08, p=0.011). During the entire study period
of ten years, the annual rate of stroke post-AMI remained stable. 
Conclusions: The present study describes specific predictors of in-hospital
and postdischarge stroke in patients with AMI, with a marked increase in the
risk of death, both during hospitalization and the year after AMI. After hos-
pital discharge, stroke remains a rare event and mostly associated with a high
cardiovascular risk.
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Background: Coronary Artery Anomalies (CAA), including anomalies of
coronary origin (ANOCOR) and ectasia or coronary aneurysms (ECTACOR)
share common entities. In coronary angiographies or autopsy series, their
prevalence range from 0.2 to 1.5%. Case control studies reported an associa-
tion between CAA and acute myocardial infarction (MI). We aimed to analyze
their prevalence, characteristics, therapeutic strategies and prognosis in
patients with acute MI.
Methods: All the consecutive patients admitted in the intensive care unit
of our hospital who underwent coronary angiography for an acute MI from
2001 to 2013 were retrospectively analysed. 
Results: Among the 9393 patients included during the study period,
80(0.92%) CAA were identified, including 37 (46%), ANOCOR and 43 (54%)
ECTACOR. Most were male (86%), with a mean age at 61±14 y, and 2.1±1.4
risk factors. The most frequent localisation of ANOCOR was the circumflex
artery (65%). The abnormal artery corresponds to the culprit lesion in 30% of
cases, and 46% had significant stenosis. In contrast, ECTACOR were mainly
localised on the right coronary artery (58%), and correspond to the culprit
lesion in 70% of the cases, and 60% had a significant stenosis. A minority, i.e.
41% of the significant lesions found on ANOCOR and 31% of those on
ECTACOR, received only a medical treatment, while 47% and 58% were
stented, or 12% and 12% underwent Coronary Artery Bypass Surgery, respec-
tively. After Percutaneous Coronary Intervention (PCI), final flow was TIMI
3 in most cases (94% and 81%, respectively). Only one patient died during the
hospital stay.
Conclusion: In our large retrospective study, the prevalence of CAAs is
consistent with older angiographic series. Culprit lesion was more frequently
associated with ECTACOR, but not with ANOCOR. The majority of signifi-
cant lesions was treated by coronary stenting with a successful angiographic
result.
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Background: Contrast-induced nephropathy (CIN) is a frequent complica-
tion in patients undergoing percutaneous coronary intervention (PCI), associ-
ated with increased mortality. The impact of metformin, which has potential
interactions with renal function, on CIN remains to be investigated.
Aim: To analyze the association between chronic metformin treatment and
the development of CIN after primary PCI for ST segment elevation myocar-
dial infarction (STEMI).
Methods: 372 patients with diabetes mellitus (DM) treated with PCI <24H
in 2 coronary care units (Paris-Bichat and Dijon Hospital, France) were
included. Serum creatinine (Cr) was measured before and 48H after PCI. CIN
was defined as an increase in Cr of 44μmol/L (0.5mg/dL) or 25% over base-
line after PCI. Since PCI was urgent, metformin could not be withheld prior
to PCI but was usually stopped after PCI. 
Results: Mean age was 66±11 y, and 25% were women. 64% had hyper-
tension, 56% had DM duration > 5 year, and 26% had prior coronary artery
disease. Metformin and sulfonylurea were the most frequently used anti-
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